TGF-β gene expression inhibitor
AssigneesNihon University, Gentier Biosystems Incorporation
InventorsNoboru Fukuda, Takahiro Ueno, Hiroshi Sugiyama
Life of this patent
Estimating the term…
Loading patent…
AssigneesNihon University, Gentier Biosystems Incorporation
InventorsNoboru Fukuda, Takahiro Ueno, Hiroshi Sugiyama
Estimating the term…
A TGF-β gene expression inhibitor containing a pyrrole-immidazole polyamide comprising an N-methylpyrrole unit (hereinafter also referred to as Py), an N-methylimidazole unit (hereinafter also referred to as Im) and a γ-aminobutyric acid unit which can be folded into an U-shaped conformation at the above-described γ-aminobutyric acid unit site in a minor groove of a double-stranded region (hereinafter referred to as the target region) containing a part or the whole of the following base sequence (SEQ ID NO: 2) corresponding to −450 to −310 of human transforming growth factor β1 (hereinafter also referred to as h TGF-β1) promoter and a strand complementary thereto and in which a Py/Im pair, an Im/Py pair and a PY/Py pair correspond respectively to a C-G base pair, a G-C base pair and an A-T base pair and a T-A base pair.
A TGF-β gene expression inhibitor comprising a pyrrole imidazole polyamide represented by the following formula:
A TGF-β gene expression inhibitor comprising a pyrrole imidazole polyamide represented by the following formula:
A pyrrole-imidazole polyamide represented by the following formulas:
Dependencies are inferred from the claim text.